Description
Inotuzumab ozogamicin (InO) shows promising efficacy and safety in ALL
Article: Inotuzumab ozogamicin (InO) shows promising efficacy and safety in ALL
€3.03
Related products
-
Article: Highlights in respiratory oncology
€3.03 Add to cart -
1 year access Online Belgian Journal of Hematology (BJH)
€71.94 Add to cart -
Article: INTRODUCTION
€3.03 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart
Reviews
There are no reviews yet.